Financial reports
10-Q
2024 Q2
Quarterly report
19 Aug 24
NT 10-Q
Notice of late quarterly filing
14 Aug 24
10-Q
2024 Q1
Quarterly report
22 May 24
NT 10-Q
Notice of late quarterly filing
15 May 24
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
16 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
10-K/A
2022 FY
Annual report (amended)
17 Oct 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
Current reports
8-K
Renowned Biotech Leader to Contribute Expertise in Neuroscience and Therapeutics Development
2 Oct 24
8-K
Departure of Directors or Certain Officers
30 Aug 24
8-K
Departure of Directors or Certain Officers
21 Aug 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
21 Aug 24
8-K
Departure of Directors or Certain Officers
5 Aug 24
8-K
Entry into a Material Definitive Agreement
27 Jun 24
8-K
Financial Statements and Notes
20 Jun 24
8-K/A
Entry into a Material Definitive Agreement
14 Jun 24
8-K
Entry into a Material Definitive Agreement
14 Jun 24
8-K
Entry into a Material Definitive Agreement
9 May 24
Registration and prospectus
424B3
Prospectus supplement
1 Oct 24
S-1/A
IPO registration (amended)
12 Sep 24
S-1
IPO registration
5 Sep 24
25-NSE
Exchange delisting
21 Jun 24
425
Business combination disclosure
20 Jun 24
425
Business combination disclosure
14 Jun 24
425
Business combination disclosure
14 Jun 24
425
Business combination disclosure
9 May 24
425
Business combination disclosure
18 Apr 24
425
Business combination disclosure
12 Apr 24
Proxies
DEFA14A
Additional proxy soliciting materials
7 Nov 23
DEFA14A
Additional proxy soliciting materials
3 Nov 23
DEF 14A
Definitive proxy
2 Nov 23
PRE 14A
Preliminary proxy
16 Oct 23
DEFA14A
Additional proxy soliciting materials
27 Mar 23
DEF 14A
Definitive proxy
20 Mar 23
PRE 14A
Preliminary proxy
24 Feb 23
Other
EFFECT
Notice of effectiveness
19 Sep 24
EFFECT
Notice of effectiveness
15 Feb 24
UPLOAD
Letter from SEC
2 Nov 23
CORRESP
Correspondence with SEC
27 Oct 23
EFFECT
Notice of effectiveness
31 Mar 22
CERT
Certification of approval for exchange listing
30 Mar 22
CORRESP
Correspondence with SEC
29 Mar 22
CORRESP
Correspondence with SEC
29 Mar 22
UPLOAD
Letter from SEC
9 Feb 22
Ownership
4
KERRY PROPPER
2 Jul 24
3
KERRY PROPPER
1 Jul 24
SC 13G
CHARDAN CAPITAL MARKETS LLC
27 Jun 24
SC 13G/A
Shaolin Capital Management LLC
22 Feb 24
SC 13G/A
MMCAP International Inc. SPC
13 Feb 24
SC 13G/A
MMCAP International Inc. SPC
14 Feb 23
SC 13G
Shaolin Capital Management LLC
13 Feb 23
SC 13G/A
Space Summit Capital LLC
8 Feb 23
SC 13G/A
Feis Lawrence
9 Jan 23
4
Change in insider ownership
11 Apr 22